SOCIETE MEDICALE GENON
0875.692.343 · rovalta.com · 26/09/2026
NORMAL SITUATION
SOCIETE MEDICALE GENON
Company — Normal situation.
Financial year 2021 · Closed on 31/12/2021
Net result41,4 k €+57,0 %over 1 year
Revenue140,4 k €-4,8 %over 1 year
Equity727,9 k €+6,0 %over 1 year
Overview
Identity
Source · BCE/KBOSOCIETE MEDICALE GENON is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0875.692.343
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2021
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2021 | 2020 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 140,4 k € | -4.8% | 147,5 k € | -7.2% | 158,9 k € | -0.9% | 160,4 k € | -16.7% | 192,6 k € |
| EBITDA | 54,4 k € | -3.8% | 56,6 k € | -11.0% | 63,6 k € | -8.5% | 69,6 k € | -37.2% | 110,8 k € |
| Operating result | 53,6 k € | +21.5% | 44,2 k € | -13.3% | 51 k € | -11.3% | 57,5 k € | -41.8% | 98,7 k € |
| Net result | 41,4 k € | +57.0% | 26,4 k € | +32.3% | 19,9 k € | -46.1% | 37 k € | -7.1% | 39,8 k € |
| Balance sheet | |||||||||
| Equity | 727,9 k € | +6.0% | 686,5 k € | +4.0% | 660,2 k € | +3.1% | 640,2 k € | +6.1% | 603,3 k € |
| Total assets | 727,9 k € | +4.0% | 699,8 k € | +5.1% | 665,9 k € | +0.5% | 662,8 k € | +4.2% | 636,2 k € |
| Cash | 2,9 k € | -75.2% | 11,8 k € | -8.8% | 12,9 k € | -14.5% | 15,1 k € | +61.7% | 9,3 k € |
| Debts | – | 13,3 k € | +132% | 5,7 k € | -74.7% | 22,5 k € | -31.6% | 32,9 k € | |
Board of directors
Source · NBB, accounts to 31/12/20201 active · 1 ended
Active mandates
Jacques GENON
ActiveEnded mandates
Jacques GENON
EndedFinancials
Full financial information
Source · NBB| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/09/2022 | 29/09/2021 | 21/09/2020 | 21/09/2019 | 16/11/2018 | 26/09/2017 |
| General meeting | 30/06/2022 | 30/06/2021 | 31/07/2020 | 02/09/2019 | 15/11/2018 | 30/06/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2021 | 30/06/2022 | 23/09/2022 | French | |
| Micro model | 31/12/2020 | 30/06/2021 | 29/09/2021 | French | |
| Micro model | 31/12/2019 | 31/07/2020 | 21/09/2020 | French | |
| Micro model | 31/12/2018 | 02/09/2019 | 21/09/2019 | French | |
| Micro model | 31/12/2017 | 15/11/2018 | 16/11/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 26/09/2017 | French | |
| Abridged model | 31/12/2015 | 20/08/2016 | 30/09/2016 | French | |
| Abridged model | 31/12/2014 | 15/09/2015 | 21/09/2015 | French | |
| Abridged model | 31/12/2013 | 30/08/2014 | 16/09/2014 | French | |
| Abridged model | 31/12/2012 | 15/09/2013 | 22/10/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 24/09/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 03/10/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 19/10/2010 | French | |
| Abridged model | 31/12/2008 | 30/06/2009 | 09/09/2009 | French | |
| Abridged model | 31/12/2007 | 30/06/2008 | 27/10/2008 | French | |
| Abridged model | 31/12/2006 | 30/06/2007 | 28/09/2007 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20201 active · 1 ended
Active mandates
Jacques GENON
ActiveEnded mandates
Jacques GENON
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 202141,4 k €↑
- 2020Annual accounts 202026,4 k €↑
- 2019Annual accounts 201919,9 k €↓
- 2018Annual accounts 201837 k €↓
- 2017Annual accounts 201739,8 k €↓
- 2016Annual accounts 201686 k €↑
- 2015Annual accounts 201575 k €↓
- 2014Annual accounts 201491 k €↑
- 2013Annual accounts 201389,9 k €↑
- 2012Annual accounts 201236,1 k €↓
- 2011Annual accounts 201193,4 k €↑
- 2010Annual accounts 201073,6 k €↑
- 2009Annual accounts 200957,6 k €↓
- 2008Annual accounts 200868,6 k €↑
- 2007Annual accounts 200727,3 k €↓
- 2006Annual accounts 200661,9 k €